These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8633048)

  • 21. Increased serum concentration of nerve growth factor in patients with microprolactinoma.
    Sigala S; Martocchia A; Missale C; Falaschi P; Spano P
    Neuropeptides; 2004 Feb; 38(1):21-4. PubMed ID: 15003712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin release, oestrogens and proliferation of prolactin-secreting cells in the anterior pituitary gland of adult male rats.
    Pérez RL; Machiavelli GA; Romano MI; Burdman JA
    J Endocrinol; 1986 Mar; 108(3):399-403. PubMed ID: 3701233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
    Martínez de la Escalera G; Guthrie J; Weiner RI
    Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential dopamine-induced prolactin mRNA levels in various prolactin-secreting cell (sub)populations.
    Kazemzadeh M; Velkeniers B; Herregodts P; Collumbien R; Finné E; Derde MP; Vanhaelst L; Hooghe-Peters EL
    J Endocrinol; 1992 Mar; 132(3):401-9. PubMed ID: 1564425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dopaminergic regulation of anterior pituitary 45Ca2+ homeostasis and prolactin secretion.
    Schrey MP; Clark HJ; Franks S
    J Endocrinol; 1986 Mar; 108(3):423-9. PubMed ID: 3486242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation and inhibition of prolactin release by prolactin-releasing Peptide in rat anterior pituitary cell aggregates.
    Swinnen E; Boussemaere M; Denef C
    J Neuroendocrinol; 2005 Jun; 17(6):379-86. PubMed ID: 15929743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
    Wang J; Ciofi P; Crowley WR
    Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproductive experience and expression of dopamine D(2) receptor mRNA: a possible mechanism for reduced prolactin secretion in primiparous rats.
    Byrnes EM; Bridges RS
    J Neuroendocrinol; 2007 Oct; 19(10):773-8. PubMed ID: 17850459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
    Pu HF; Liu TC
    J Cell Biochem; 2002; 86(2):268-76. PubMed ID: 12111996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NGF and BDNF in the anterior pituitary lobe of adult rats.
    Höpker VH; Amoureux MC; Varon S
    J Neurosci Res; 1997 Aug; 49(3):355-63. PubMed ID: 9260746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of prolactin secretion by dopamine and vasoactive intestinal peptide at the level of the pituitary in the turkey.
    Youngren OM; Chaiseha Y; El Halawani ME
    Neuroendocrinology; 1998 Nov; 68(5):319-25. PubMed ID: 9822799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism.
    Missale C; Losa M; Sigala S; Balsari A; Giovanelli M; Spano PF
    Mol Endocrinol; 1996 Mar; 10(3):272-85. PubMed ID: 8833656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of neurotrophin expression in basal forebrain astrocytes by neuronal signals.
    Wu H; Friedman WJ; Dreyfus CF
    J Neurosci Res; 2004 Apr; 76(1):76-85. PubMed ID: 15048931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased adrenoceptor stimulation in heart failure rats reduces NGF expression by cardiac parasympathetic neurons.
    Hasan W; Smith PG
    Auton Neurosci; 2014 Apr; 181():13-20. PubMed ID: 24332566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line.
    Missale C; Castelletti L; Boroni F; Memo M; Spano P
    Endocrinology; 1991 Jan; 128(1):13-20. PubMed ID: 1670924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-alpha gene expression and growth in anterior pituitary, but not in uterus.
    Borgundvaag B; Kudlow JE; Mueller SG; George SR
    Endocrinology; 1992 Jun; 130(6):3453-8. PubMed ID: 1534540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nerve growth factor derived from terminals selectively increases the ratio of p75 to trkA NGF receptors on mature sympathetic neurons.
    Miller FD; Speelman A; Mathew TC; Fabian J; Chang E; Pozniak C; Toma JG
    Dev Biol; 1994 Jan; 161(1):206-17. PubMed ID: 8293873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific induction of a functional endogenous D2 short dopamine receptor in GH4C1 cells.
    Allard S; Lapointe S; Falardeau P
    Biochem Biophys Res Commun; 1993 Jun; 193(2):801-7. PubMed ID: 8390254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.